Clinical Trial Update: buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating burst suppression to stop refractory status epilepticus following cardiac arrest; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anoxic-ischemic Encephalopathy
• Hypoxic-ischemic Brain Injury
• Status Epilepticus

Snippet

Sponsor: University of California, San Francisco | Conditions: Hypoxia-Ischemia, Brain, Heart Arrest | Phase 2 | Status: RECRUITING